Obalon Announces FDA Approval of Obalon Navigation System
December 21, 2018 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Key Weight Loss and Safety Data Presented for the Obalon Swallowable Gas-Filled Balloon System at the 35th ASMBS Annual Meeting at Obesity Week 2018
November 15, 2018 09:15 ET
|
Obalon Therapeutics, Inc.
Clinical results presented from over 1,300 patients treated at 108 sites with Obalon’s non-surgical weight loss solution in commercial setting SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Obalon...
Obalon Balloon System Data to be Featured in Presentation During 35th ASMBS Annual Meeting at Obesity Week 2018
November 07, 2018 09:15 ET
|
Obalon Therapeutics, Inc.
Clinical results from over 1,300 patients at 108 sites treated with Obalon’s novel weight loss device solution in commercial use SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics,...
Obalon Announces Upcoming Conference Presentations
November 06, 2018 09:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Third Quarter 2018 Financial Results
November 02, 2018 08:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules Third Quarter 2018 Financial Results Conference Call for November 2, 2018 at 8:30 a.m. Eastern Time
October 23, 2018 09:04 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable,...
Daina Schmidt Joins Obalon Therapeutics As Vice President, Marketing
October 09, 2018 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
FDA Grants PMA-S Approval for Obalon Touch™ Inflation System
September 26, 2018 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon to Host Corporate Strategy Update Call with Investors and Analysts on September 10, 2018
August 29, 2018 09:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics Announces Closing of $10 Million Private Placement
August 27, 2018 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...